Oncostability: stability of reconstituted and diluted anticancer medicines for a possible extension of use | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PostScript

Letter

Oncostability: stability of reconstituted and diluted anticancer medicines for a possible extension of use

Online download statistics by month:

Online download statistics by month: December 2021 to March 2024

	Abstract	Full	Pdf
Dec 2021	1872	6	7
Jan 2022	705	14	8
Feb 2022	475	2	1
Mar 2022	280	0	1
Apr 2022	258	2	2
May 2022	231	0	0
Jun 2022	248	2	1
Jul 2022	242	6	1
Aug 2022	430	6	1
Sep 2022	770	16	2
Oct 2022	234	5	1
Nov 2022	274	3	0
Dec 2022	194	0	1
Jan 2023	178	2	3
Feb 2023	158	1	1
Mar 2023	115	20	7
Apr 2023	38	38	9
May 2023	48	23	9
Jun 2023	72	7	5
Jul 2023	89	0	3
Aug 2023	110	1	0
Sep 2023	39	0	0
Oct 2023	36	2	0
Nov 2023	42	1	0
Dec 2023	41	2	2
Jan 2024	32	0	3
Feb 2024	36	2	3
Mar 2024	70	1	1
Total	7317	162	72